Orgenesis Profit Margin

As of the most recent data (September 2024), ORGS shows a profit margin of 1.92%. That compares with 10.78% in the prior-year period — up 1676.0% year over year. That is above the Healthcare sector average of 15.58%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ORGS's profit margin is now 1.92% (was 10.78%) — a 1676.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Orgenesis is outperforming or lagging.

The Healthcare sector average profit margin is about 15.58%. Orgenesis is at 1.92%, which is higher that average. That is roughly 1129.0% above the sector mean. Use the comparison chart on this page to see how ORGS stacks up against individual peers as well.

That compares with 10.78% in the prior-year period — up 1676.0% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Orgenesis with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Orgenesis's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 1.92%) with ownership activity and broader fundamentals.